Cargando…

Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults

A Gamma Variant RBD-based aluminum hydroxide adjuvanted vaccine called ARVAC CG was selected for a first in human clinical trial. Healthy male and female participants (18-55 years old) with a complete COVID-19-primary vaccine scheme were assigned to receive two intramuscular doses of either a low-do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasquevich, Karina A., Coria, Lorena M., Ceballos, Ana, Mazzitelli, Bianca, Rodriguez, Juan Manuel, Demaría, Agostina, Pueblas Castro, Celeste, Bruno, Laura, Saposnik, Lucas, Salvatori, Melina, Varese, Augusto, González, Soledad, González Martínez, Veronica V., Geffner, Jorge, Álvarez, Diego, Feleder, Ethel, Halabe, Karina, Perez Lera, Pablo E., de Oca, Federico Montes, Vega, Julio C., Lombardo, Mónica, Yerino, Gustavo A., Fló, Juan, Cassataro, Juliana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382514/ https://www.ncbi.nlm.nih.gov/pubmed/37507392 http://dx.doi.org/10.1038/s41467-023-40272-3

Ejemplares similares

A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice
por: Coria, Lorena M., et al.
Publicado: (2022)

U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge
por: Coria, Lorena M., et al.
Publicado: (2020)

A disordered region retains the full protease inhibitor activity and the capacity to induce CD8(+) T cells in vivo of the oral vaccine adjuvant U-Omp19
por: Laura Darriba, M., et al.
Publicado: (2022)

Biopharmaceutical Characteristics of Nifurtimox Tablets for Age‐ and Body Weight‐Adjusted Dosing in Patients With Chagas Disease
por: Stass, Heino, et al.
Publicado: (2020)

Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier
por: Coria, Lorena M., et al.
Publicado: (2019)

Stability Studies of the Vaccine Adjuvant U-Omp19
por: Darriba, M. Laura, et al.
Publicado: (2021)

Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System
por: Pasquevich, Karina A., et al.
Publicado: (2019)

U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice
por: Risso, Gabriela S., et al.
Publicado: (2017)

An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice
por: Pasquevich, Karina A., et al.
Publicado: (2011)

Unlipidated Outer Membrane Protein Omp16 (U-Omp16) from Brucella spp. as Nasal Adjuvant Induces a Th1 Immune Response and Modulates the Th2 Allergic Response to Cow’s Milk Proteins
por: Ibañez, Andrés E., et al.
Publicado: (2013)

Prostaglandin E2 Antagonizes TGF-β Actions During the Differentiation of Monocytes Into Dendritic Cells
por: Remes Lenicov, Federico, et al.
Publicado: (2018)

Immune Maturation Effects on Viral Neutralization and Avidity of Hyperimmunized Equine Anti-SARS-CoV-2 Sera
por: González Viacava, Myriam Belén, et al.
Publicado: (2022)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
por: Junker, Daniel, et al.
Publicado: (2022)

Low pH impairs complement-dependent cytotoxicity against IgG-coated target cells
por: Dantas, Ezequiel, et al.
Publicado: (2016)

An Approach for Easy Detection of Buried FRP Composite/Non-Metallic Pipes Using Ground-Penetrating Radar
por: Kavi, Jonas, et al.
Publicado: (2023)

Mutated trimeric RBD vaccines: a platform against variants of concern
por: Aparicio, Belén, et al.
Publicado: (2023)

Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers
por: Ribeiro, Isabela, et al.
Publicado: (2021)

Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people
por: Rouco, Santiago Oviedo, et al.
Publicado: (2022)

Predictors of RBD progression and conversion to synucleinopathies
por: de Natale, Edoardo Rosario, et al.
Publicado: (2022)

Immunogenicity induced by the use of alternative vaccine platforms to deal with vaccine shortages in a low- to middle-income country: Results of two randomized clinical trials
por: Macchia, Alejandro, et al.
Publicado: (2022)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD
por: Gong, Si-Yi, et al.
Publicado: (2022)

Aprendizaje basado en proyectos en la enseñanza de la Bibliotecología: innovaciones pedagógicas en y fuera de las aulas
por: Corda, María Cecilia, et al.
Publicado: (2020)

SAT-455 Analysis of a Group of Prolactinomas Resistant to Treatment with Dopamine Agonists at a University Hospital in Buenos Aires, Argentina
por: Gonzalez Pernas, Mariana, et al.
Publicado: (2019)

Reduced Intracortical Facilitation to TMS in Both Isolated REM Sleep Behavior Disorder (RBD) and Early Parkinson’s Disease with RBD
por: Lanza, Giuseppe, et al.
Publicado: (2022)

Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells
por: Gerez, Guillaume, et al.
Publicado: (2022)

Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
por: Shi, Juan, et al.
Publicado: (2023)

Suprasellar chordoid glioma: a report of two cases
por: Danilowicz, Karina, et al.
Publicado: (2018)

Imagen, icono, ilusión : investigaciones sobre algunos problemas de la representación visual
por: Fló, Juan
Publicado: (2010)

Contribution of dsRBD2 to PKR Activation
por: Hesler, Stephen, et al.
Publicado: (2021)

Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11
por: Tolbert, William D., et al.
Publicado: (2023)

Triterpene Derivatives as Potential Inhibitors of the RBD Spike Protein from SARS-CoV-2: An In Silico Approach
por: Avelar, Mayra, et al.
Publicado: (2023)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
por: Dickey, Thayne H., et al.
Publicado: (2022)

Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA
por: Li, Yuanyuan, et al.
Publicado: (2017)

Neurologic and psychiatric features of impending neurodegeneration in iRBD
por: Barone, Daniel A., et al.
Publicado: (2023)

Entropic contribution of ACE2 glycans to RBD binding
por: Mugnai, Mauro L., et al.
Publicado: (2023)

Data set of dissolved major and trace elements from the lacustrine systems of Clearwater Mesa, Antarctica
por: Lecomte, Karina L., et al.
Publicado: (2020)

The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD
por: Greaney, Allison J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_us5npmlr6a61tl12ofnlh57vu9